跳至主要内容
临床试验/CTRI/2022/11/047694
CTRI/2022/11/047694尚未招募2 期

A randomized standard controlled clinical trial to assess the efficacy of Gandharvahastyaadi choorna in the management of Mutrashmari

Dr Sushil Rohidas Ranjane0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patients of calculus of age group (above 15 years) irrespective of sex and occupation are included.
  • 2 Renal and Ureteric calculus less than 10mm of size.
  • 3 Patientsâ?? having classical signs and symptoms of Mutrashmari are included.
  • 4 Uncomplicated Patients having with or without mild
  • Hydronephrosis will be selected randomly.

排除标准

  • 1 Patients with systemic pathology (Uncontrolled DM, Hypertension etc.)and any Urinary obstructive condition. (Impaired Renal Function, enlarged
  • 2 Known case of Covid -19.
  • 3 Patient suffering from any systemic disease such as Kochsâ??s , Bronchial
  • Asthma, Ischemic Heart Disease, Chronic Kidney Disease and Convulsive disorders like Epilepsy, Meningitis which will interfere with the course of treatment.
  • 4 Patients having Moderate or Severe Hydronephrosis.
  • 5 Patients who deny giving written informed consent.

研究者

发起方
Dr Sushil Rohidas Ranjane

相似试验